Central Sleep Apnea and Hypoventilation Syndrome
Related Experiment Video
Updated: Oct 10, 2026

A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
1Respiratory Division, Department of Medicine, University of British Columbia and Vancouver Hospital, 2775 Heather Street, Vancouver, British Columbia V5Z 3J5, Canada.
Abstract:
Central sleep apnea hypopnea syndrome (CSAHS) and sleep hypoventilation syndrome (SHVS) are two distinct clinical syndromes with clearly defined diagnostic criteria. It is important to distinguish between normo/hypocapnic and hypercapnic CSAHS prior to treatment. Nasal continuous positive airway pressure is currently considered the primary treatment of choice for normo/hypocapnic CSAHS. The initial management of hypercapnic CSAHS and SHVS should include identification of any treatable causes and discontinuation of any sedative medications. Medroxyprogesterone may be effective in the long term management of these patients. If pharmacologic therapy fails, assisted ventilation should be considered. Assisted ventilation during the night is usually sufficient to improve hypercapnia and hypoxemia both at night and during the day. Assisted ventilation is usually best administered through a tight fitting nasal mask.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Hyperpnea and Hyperventilation
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes include...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Acute Respiratory Failure-III
